Boston Partners’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOL
PCMI
Boston Partners's BIOL Position: Q4 2015 in Review
Boston Partners sold out of Biolase (BIOL) in Q4 2015, closing a stake of 109 shares — an estimated $1.23M sold.
Boston Partners first reported a position in BIOL in Q2 2015 and held it in 2 quarters. The position peaked at $2.49M in Q2 2015. 30 funds tracked by Wall St. Rank hold BIOL as of Q4 2015.
- Boston Partners reported no remaining Biolase position as of Q4 2015 after selling out during the quarter.
- Boston Partners sold 109 Biolase shares in Q4 2015, an estimated $1.23M.
- Boston Partners first reported a position in Biolase in Q2 2015 and held it in 2 quarters.
- Boston Partners's Biolase position peaked at $2.49M in Q2 2015.
- 30 funds tracked by Wall St. Rank held Biolase as of Q4 2015.
Based on Boston Partners's 13F filing for Q4 2015, filed 8 Feb 2016.